ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 259 filers reported holding ACCELERON PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $214,335,000 | +36.8% | 1,245,412 | -0.2% | 0.36% | +56.7% |
| Q2 2021 | $156,628,000 | -32.9% | 1,248,131 | -27.5% | 0.23% | -33.4% |
| Q1 2021 | $233,484,000 | +6.2% | 1,721,731 | +0.2% | 0.35% | -3.1% |
| Q4 2020 | $219,855,000 | +20.2% | 1,718,421 | +5.7% | 0.36% | +5.6% |
| Q3 2020 | $182,929,000 | +28.0% | 1,625,606 | +8.3% | 0.34% | -6.4% |
| Q2 2020 | $142,963,000 | +15.4% | 1,500,606 | +8.9% | 0.36% | -31.6% |
| Q1 2020 | $123,836,000 | +304.1% | 1,377,950 | +138.4% | 0.53% | +364.0% |
| Q4 2019 | $30,643,000 | -17.8% | 577,950 | -38.8% | 0.11% | -13.0% |
| Q3 2019 | $37,295,000 | -3.8% | 943,950 | 0.0% | 0.13% | -14.9% |
| Q2 2019 | $38,778,000 | -1.3% | 943,950 | +11.8% | 0.15% | -21.4% |
| Q1 2019 | $39,303,000 | +141.3% | 843,950 | +125.7% | 0.20% | +84.9% |
| Q4 2018 | $16,286,000 | +4.5% | 373,950 | +37.3% | 0.11% | +43.2% |
| Q3 2018 | $15,585,000 | – | 272,329 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 3,133,234 | $124,076,000 | 82.43% |
| Deer VII & Co. Ltd. | 1,105,964 | $39,417,000 | 9.51% |
| Foresite Capital Management I, LLC | 66,000 | $2,614,000 | 2.54% |
| QVT Financial LP | 556,574 | $21,592,000 | 1.27% |
| Orbimed Advisors | 2,117,648 | $83,859,000 | 1.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $1,980,000 | 0.55% |
| WALL STREET ASSOCIATES | 93,800 | $3,714,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 197,219 | $7,810,000 | 0.28% |
| EAM Investors, LLC | 37,871 | $1,500,000 | 0.27% |
| Granite Point Capital Management, L.P. | 30,000 | $1,188,000 | 0.20% |